[1]
Mangilipally, S., Lingala, D., Dusa, J., S, A.T., Bogi, N., Aeluka, R. and D, P. 2026. Regulatory Pathways for Generic Antiviral Drugs: ANDA Requirements in the USA Compared With BRICS. International Journal of Life Science and Pharma Research. 16, 3 (Nov. 2026), 64–75. DOI:https://doi.org/10.22376/ijlpr.v16i3.2059.